⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 19 July, 2016    By - Dr Clemens
What If Price Transparency Doesn’t Lower Healthcare Spending?

While surgical price transparency is gaining popularity among facilities seeking a competitive edge, researchers report that online cost comparison tools may actually end up increasing healthcare spending. For their study, published in JAMA, the Harvard Medical School researchers found that only a small percentage of eligible employees at 2 large companies used an online price transparency tool […]

Read More
Uncategorized Published - 19 July, 2016    By - Dr Clemens
Researchers: Drop the No-Eating Rule Before Colonoscopy

There may be a better way to get stubborn or procrastinating patients to sign up for potentially life-saving colonoscopies: Let ’em eat macaroni and cheese. Researchers speculate that a 1-day, low-residue diet — which could include such foods as scrambled eggs, white bread, butter, chicken breasts, pretzels and good old mac-and-cheese — as opposed to the […]

Read More
Uncategorized Published - 19 July, 2016    By - Dr Clemens
Benzodiazepines Are Often Inappropriately Prescribed

Benzodiazepines are prescribed disproportionately to patients who either do not have a clear indication or have poor indications, such as depression, new data show. This leads to higher healthcare usage, greater health risk, and increased costs. The drugs are commonly prescribed for anxiety and sleep disorders, but have known risks for adverse events in the […]

Read More
Uncategorized Published - 19 July, 2016    By - Dr Clemens
Lilly Says New Type of Pain Drug Could Lessen Need for Opioids

Eli Lilly and Co on Tuesday said it and partner Pfizer Inc aim to seek approval by 2018 for a new type of pain drug that could be an alternative to opioids for osteoarthritis, chronic back pain and cancer pain. The Indianapolis drugmaker said tanezumab, given by injection every eight weeks, could be a far […]

Read More
Uncategorized Published - 19 July, 2016    By - Dr Clemens
Buprenorphine: Long-term Efficacy for Opioid Dependence

As prescription opioid use disorder reaches epidemic proportions in the United States, finding successful treatments for the condition has become hugely important. Now, research shows that treating opioid-dependent patients with buprenorphine, a partial μ-opioid agonist and κ-opioid antagonist, appears to reduce the need for opioids. Presented here at the American Psychiatric Association (APA) 2016 Annual […]

Read More